Cite This Page
Bibliographic details for Lymphoblastic predominance associated with blastic cycle in youngsters along with longterm myeloid leukaemia helped by imatinib An investigation in the ICMLPed Examine
- Page name: Lymphoblastic predominance associated with blastic cycle in youngsters along with longterm myeloid leukaemia helped by imatinib An investigation in the ICMLPed Examine
- Author: OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors
- Publisher: OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, .
- Date of last revision: 17 January 2024 08:38 UTC
- Date retrieved: 28 April 2024 18:46 UTC
- Permanent URL: https://news.npo.digital/index.php?title=Lymphoblastic_predominance_associated_with_blastic_cycle_in_youngsters_along_with_longterm_myeloid_leukaemia_helped_by_imatinib_An_investigation_in_the_ICMLPed_Examine&oldid=549492
- Page Version ID: 549492
Citation styles for Lymphoblastic predominance associated with blastic cycle in youngsters along with longterm myeloid leukaemia helped by imatinib An investigation in the ICMLPed Examine
APA style
Lymphoblastic predominance associated with blastic cycle in youngsters along with longterm myeloid leukaemia helped by imatinib An investigation in the ICMLPed Examine. (2024, January 17). OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, . Retrieved 18:46, April 28, 2024 from https://news.npo.digital/index.php?title=Lymphoblastic_predominance_associated_with_blastic_cycle_in_youngsters_along_with_longterm_myeloid_leukaemia_helped_by_imatinib_An_investigation_in_the_ICMLPed_Examine&oldid=549492.
MLA style
"Lymphoblastic predominance associated with blastic cycle in youngsters along with longterm myeloid leukaemia helped by imatinib An investigation in the ICMLPed Examine." OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, . 17 Jan 2024, 08:38 UTC. 28 Apr 2024, 18:46 <https://news.npo.digital/index.php?title=Lymphoblastic_predominance_associated_with_blastic_cycle_in_youngsters_along_with_longterm_myeloid_leukaemia_helped_by_imatinib_An_investigation_in_the_ICMLPed_Examine&oldid=549492>.
MHRA style
OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors, 'Lymphoblastic predominance associated with blastic cycle in youngsters along with longterm myeloid leukaemia helped by imatinib An investigation in the ICMLPed Examine', OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, , 17 January 2024, 08:38 UTC, <https://news.npo.digital/index.php?title=Lymphoblastic_predominance_associated_with_blastic_cycle_in_youngsters_along_with_longterm_myeloid_leukaemia_helped_by_imatinib_An_investigation_in_the_ICMLPed_Examine&oldid=549492> [accessed 28 April 2024]
Chicago style
OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors, "Lymphoblastic predominance associated with blastic cycle in youngsters along with longterm myeloid leukaemia helped by imatinib An investigation in the ICMLPed Examine," OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, , https://news.npo.digital/index.php?title=Lymphoblastic_predominance_associated_with_blastic_cycle_in_youngsters_along_with_longterm_myeloid_leukaemia_helped_by_imatinib_An_investigation_in_the_ICMLPed_Examine&oldid=549492 (accessed April 28, 2024).
CBE/CSE style
OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors. Lymphoblastic predominance associated with blastic cycle in youngsters along with longterm myeloid leukaemia helped by imatinib An investigation in the ICMLPed Examine [Internet]. OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, ; 2024 Jan 17, 08:38 UTC [cited 2024 Apr 28]. Available from: https://news.npo.digital/index.php?title=Lymphoblastic_predominance_associated_with_blastic_cycle_in_youngsters_along_with_longterm_myeloid_leukaemia_helped_by_imatinib_An_investigation_in_the_ICMLPed_Examine&oldid=549492.
Bluebook style
Lymphoblastic predominance associated with blastic cycle in youngsters along with longterm myeloid leukaemia helped by imatinib An investigation in the ICMLPed Examine, https://news.npo.digital/index.php?title=Lymphoblastic_predominance_associated_with_blastic_cycle_in_youngsters_along_with_longterm_myeloid_leukaemia_helped_by_imatinib_An_investigation_in_the_ICMLPed_Examine&oldid=549492 (last visited April 28, 2024).
BibTeX entry
@misc{ wiki:xxx, author = "OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK", title = "Lymphoblastic predominance associated with blastic cycle in youngsters along with longterm myeloid leukaemia helped by imatinib An investigation in the ICMLPed Examine --- OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK{,} ", year = "2024", url = "https://news.npo.digital/index.php?title=Lymphoblastic_predominance_associated_with_blastic_cycle_in_youngsters_along_with_longterm_myeloid_leukaemia_helped_by_imatinib_An_investigation_in_the_ICMLPed_Examine&oldid=549492", note = "[Online; accessed 28-April-2024]" }
When using the LaTeX package url (\usepackage{url}
somewhere in the preamble) which tends to give much more nicely formatted web addresses, the following may be preferred:
@misc{ wiki:xxx, author = "OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK", title = "Lymphoblastic predominance associated with blastic cycle in youngsters along with longterm myeloid leukaemia helped by imatinib An investigation in the ICMLPed Examine --- OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK{,} ", year = "2024", url = "\url{https://news.npo.digital/index.php?title=Lymphoblastic_predominance_associated_with_blastic_cycle_in_youngsters_along_with_longterm_myeloid_leukaemia_helped_by_imatinib_An_investigation_in_the_ICMLPed_Examine&oldid=549492}", note = "[Online; accessed 28-April-2024]" }